Navigation Links
B. Braun's DoseTrac(TM) Software: Making Connections to Better Manage IV Therapy
Date:11/24/2008

Industry-First Inbound ADT Capability in DoseTrac(TM) Improves Communication and Safety, Promotes Ease of Use

BETHLEHEM, Pa., Nov. 24 /PRNewswire/ -- In an industry first that will help healthcare providers improve patient safety and reduce medication errors as they streamline care, B. Braun Medical Inc. (B. Braun) announces the launch of its DoseTrac(TM) Infusion Management Software with Inbound Admission, Discharge and Transfer (ADT) Interface capabilities.

(LOGO: http://www.newscom.com/cgi-bin/prnh/20081022/NYW008LOGO )

A leader in infusion therapy, B. Braun was the first infusion pump vendor to offer real-time wireless information when it introduced its DoseTrac(TM) Infusion Management Software. The ADT Interface capability, also an industry-first, makes connectivity easier and less expensive. It's one of a series of connectivity programs the company expects to introduce for DoseTrac(TM) to support better communication among clinical, administrative and ancillary applications.

The ADT Interface allows room and bed information to be posted to real-time views and specified reports within DoseTracTM. Providing more specific information, the ADT Interface allows clinicians to be more effective and time efficient. For example, clinicians with access to the ADT information spend less time finding pumps that are reporting alerts or alarms and more time caring for patients.

"Patient specific information such as room and bed is readily available within B. Braun's DoseTrac(TM) Software and eliminates the need to search and/or cross-reference other systems," said Debby Cowan, Director of Pharmacy for Angel Medical Center. "Timing is critical, especially when it comes to infusion therapy within a fast-paced hospital environment. DoseTrac(TM) with ADT Interface enables quicker decision making, improved follow up by our clinicians and better outcomes for our patients."

For example, when an alarm sounds on an infusion pump, DoseTrac(TM) with ADT will highlight the alarm for clinicians and provide them with detailed information - including bed number - so they can quickly identify the alarm's location, as well as why it's sounding.

"The addition of an ADT Interface to our DoseTrac(TM) Software demonstrates B. Braun's commitment to develop solutions that create connectivity within the healthcare setting and work within the medical device industry to implement standards for connectivity and care," said Gale White, Vice President of Infusion Systems for B. Braun Medical Inc. "We will continue to partner with organizations like Integrating the Healthcare Enterprise - Patient Care Device (IHE-PCD) domain to ensure that patients and providers enjoy the benefits of connectivity."

DoseTrac(TM) with ADT Interface receives real-time notification of patient arrivals, movements and departures, to help improve the efficiency of the services provided by clinicians. In-depth patient information and locations are received and posted in real-time to specific views and reports within DoseTracTM to help healthcare professionals better interpret and make use of infusion information.

B. Braun was the first infusion systems vendor to offer and implement IHE interface-based standards commercially with the new ADT Software. IHE, an initiative by healthcare professionals and the industry to improve the way healthcare computer systems share information, promotes the coordinated use of established standards such as DICOM, IEEE and HL7 to address specific clinical needs in support of optimal patient care. Systems developed in accordance with IHE communicate with one another better, are easier to implement and enable care providers to use information more effectively.

B. Braun's DoseTrac(TM) Infusion Management Software provides hospitals with the ability to monitor, trend, report and manage the IV administration process and make the information available to end users and other hospital information management systems. A server application that collects and stores wireless infusion information in a database, DoseTrac(TM) Software uses real-time wireless information transmitted from the Outlook(R) Safety Infusion System from multiple departments. DoseTrac(TM) Software also allows clinicians to view real-time wireless information transmitted from the operational pumps while collecting this valuable data for retrospective reporting capabilities.

Detailed information about B. Braun's Outlook(R) Safety Infusion System is available on a special Web site, http://www.bbraunusa-smartpumps.com/dosetracnews.

About B. Braun

B. Braun is a global leader in infusion therapy and pain management and a pioneer in passive safety devices and PVC-/DEHP-free products. Every day, B. Braun employees worldwide share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance safety for patients, physicians and nurses.

Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun promotes best practices for continuous improvement of healthcare and, guided by its "Sharing Expertise" philosophy, helps today's healthcare workers address critical issues including environmental responsibility, medication errors reduction and infection prevention. For more information, call 800-227-2862, e-mail us at inquiry.us@bbraun.com or visit B. Braun at www.bbraunusa.com.


'/>"/>
SOURCE B. Braun
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. DecisionView Unveils the Next Generation of Clinical Trial Software: StudyOptimizer 4.0
2. Heres What It Takes ... to Be Healthy, Wealthy, and Wise: New Self-Help Book Sees Life as Pieces of a Puzzle, Offers Advice on Making Those Pieces Fit
3. Need Help Making Medicare Work for You?
4. Economic Crisis Making You Anxious or Depressed?
5. New guide explores making the most of Social Security
6. Notice of Proposed Rulemaking on U.S. Department of Labors Risk Assessment Procedures Published in Federal Register
7. Teens making poor choices when it comes to riding in vehicles
8. Making good fat from muscle and vice versa
9. AUDIO from Medialink and Pfizer: Community Health Centers Celebrated for Making Quality Care Available to Uninsured Americans
10. Making Sudden Cardiac Arrest a National Health Priority: National Medical Association Issues White Paper on Sudden Cardiac Arrest
11. Making patients move requires the right exercise advice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/22/2017)... 22, 2017 AVACEN Medical (AVACEN) announced that ... successfully helping those with the widespread pain associated with ... Amanda in Essex, England commented, ... hair, experiencing no sleep at all, tremendous pain, with ... cannot recommend [the AVACEN 100] enough, how this has ...
Breaking Medicine Technology: